Prostate Cancer

 Make Your Own
 Colcom Books for Sale
 In & Out Of Sync
 Murder Mystery Dinner
 Local Shared Ministry
 Prostate Cancer
 Family History
 Visist Dave's Blog
 Contact Us

Prostate Cancer

When Dave got the diagnosis in 2002 we were faced with some difficult choices as to therapy. We opted for surgery and went onto the waiting list at Whangarei Base Hospital.

But about the time his name was coming up on the list he had emergency surgery for a congenital adhesion that suddenly caused a massive blockage. They wouldn’t put in a zip so a few weeks later the same incision was re-opened for the prostatectomy.

Unfortunately, his PSA became readable about a year later so for a time we “watched and waited” while it climbed steadily. When we judged it had gone far enough he went onto three-monthly Zoladex implants. These stopped the PSA in its tracks but also stopped some other interesting things with the usual side-effects. And in a year the PSA became measurable again.

So he’s been on daily Bicalutamide tablets as well as Zoladex for about three years and his PSA reading became readable again in 2011. That’s not a bad story up to this point, thanks to early intervention and some great professional assistance. However, two years later his PSA was going up rapidly and we made the decision to move to Hibiscus Coast Village near Auckland.

Here we found that North Shore Hospital was one of only three in the country promoting a new drug trial and the process of entering this revealed the location of the cancer which had progressed beyond the prostrate region. This diagnosis was followed by a short series of radiation on the area, resulting in a dramatic set-back of Dave's PSA. However, a year later it resumed a steep upward climb. In early 2016 he is on an additional medication and his doubling rate of PSA seems to be something under six months.

Dave’s light-hearted little book of limericks about his surgery still expresses the positive outlook that we both have as we journey on with Ca Pros. Ask for a free copy.